| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
|
Péntek, Márta
|
|
2014
|
|
supplement-1 |
p. 73-82
|
artikel
|
| 2 |
A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
|
Zrubka, Zsombor
|
|
2019
|
|
supplement-1 |
p. 119-132
|
artikel
|
| 3 |
Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries
|
Gulácsi, László
|
|
2014
|
|
supplement-1 |
p. 1-4
|
artikel
|
| 4 |
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
|
Péntek, Márta
|
|
2014
|
|
supplement-1 |
p. 35-43
|
artikel
|
| 5 |
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
|
Brodszky, Valentin
|
|
2014
|
|
supplement-1 |
p. 65-71
|
artikel
|
| 6 |
Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer
|
Schulenburg, J.-Matthias von der
|
|
2009
|
|
supplement-1 |
p. 21-26
|
artikel
|
| 7 |
Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010
|
Boncz, Imre
|
|
2014
|
|
supplement-1 |
p. 137-141
|
artikel
|
| 8 |
Colocteral cancer management and prevention policies in Greece
|
Geitona, Mary
|
|
2009
|
|
supplement-1 |
p. 27-33
|
artikel
|
| 9 |
Colorectal cancer care in Denmark: status and dilemmas
|
Vrangbaek, Karsten
|
|
2009
|
|
supplement-1 |
p. 5-13
|
artikel
|
| 10 |
Colorectal cancer in France
|
Chevreul, Karine
|
|
2009
|
|
supplement-1 |
p. 15-20
|
artikel
|
| 11 |
Colorectal cancer in Italy: a review of current national and regional practice on screening and treatment
|
Masseria, Cristina
|
|
2009
|
|
supplement-1 |
p. 41-49
|
artikel
|
| 12 |
Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?
|
Verastegui, Emma
|
|
2009
|
|
supplement-1 |
p. 107-114
|
artikel
|
| 13 |
Colorectal cancer in Portugal
|
Pinto, Carlos Gouveia
|
|
2009
|
|
supplement-1 |
p. 65-73
|
artikel
|
| 14 |
Colorectal cancer in Russia
|
Avksentyeva, Maria
|
|
2009
|
|
supplement-1 |
p. 91-98
|
artikel
|
| 15 |
Colorectal cancer in Turkey: current situation and challenges for the future
|
Tatar, Mehtap
|
|
2009
|
|
supplement-1 |
p. 99-105
|
artikel
|
| 16 |
Colorectal cancer management in Poland: current improvements and future challenges
|
Ruszkowski, Jacek
|
|
2009
|
|
supplement-1 |
p. 57-63
|
artikel
|
| 17 |
Colorectal cancer management in the United Kingdom: current practice and challenges
|
Schurer, Willemien
|
|
2009
|
|
supplement-1 |
p. 85-90
|
artikel
|
| 18 |
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
|
Baji, Petra
|
|
2014
|
|
supplement-1 |
p. 45-52
|
artikel
|
| 19 |
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
|
Balogh, Orsolya
|
|
2014
|
|
supplement-1 |
p. 101-109
|
artikel
|
| 20 |
Cost-of-illness studies in nine Central and Eastern European countries
|
Brodszky, Valentin
|
|
2019
|
|
supplement-1 |
p. 155-172
|
artikel
|
| 21 |
Dealing with the health state ‘dead’ when using discrete choice experiments to obtain values for EQ-5D-5L heath states
|
Ramos-Goñi, Juan Manuel
|
|
2013
|
|
supplement-1 |
p. 33-42
|
artikel
|
| 22 |
Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
|
Zrubka, Zsombor
|
|
2019
|
|
supplement-1 |
p. 31-41
|
artikel
|
| 23 |
Development of health economics in Hungary between 1990–2006
|
|
|
2007
|
|
supplement-1 |
p. 4-6
|
artikel
|
| 24 |
Economic burden of long-term care of rheumatoid arthritis patients in Hungary
|
Horváth, Zoltán
|
|
2014
|
|
supplement-1 |
p. 131-135
|
artikel
|
| 25 |
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
|
Baji, Petra
|
|
2014
|
|
supplement-1 |
p. 53-64
|
artikel
|
| 26 |
EQ-5D studies in nervous system diseases in eight Central and East European countries: a systematic literature review
|
Prevolnik Rupel, Valentina
|
|
2019
|
|
supplement-1 |
p. 109-117
|
artikel
|
| 27 |
Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
|
Mandel, Michael D.
|
|
2014
|
|
supplement-1 |
p. 129
|
artikel
|
| 28 |
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
|
Herédi, Emese
|
|
2014
|
|
supplement-1 |
p. 111-119
|
artikel
|
| 29 |
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
|
Gulácsi, László
|
|
2014
|
|
supplement-1 |
p. 13-25
|
artikel
|
| 30 |
Introducing the composite time trade-off: a test of feasibility and face validity
|
Janssen, Bas M. F.
|
|
2013
|
|
supplement-1 |
p. 5-13
|
artikel
|
| 31 |
Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
|
Weszl, Miklós
|
|
2019
|
|
supplement-1 |
p. 133-140
|
artikel
|
| 32 |
Lead versus lag-time trade-off variants: does it make any difference?
|
Augustovski, Federico
|
|
2013
|
|
supplement-1 |
p. 25-31
|
artikel
|
| 33 |
One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands
|
Shah, Koonal K.
|
|
2013
|
|
supplement-1 |
p. 65-73
|
artikel
|
| 34 |
Oral presentations
|
|
|
2007
|
|
supplement-1 |
p. 7-104
|
artikel
|
| 35 |
Patient and general population values for luminal and perianal fistulising Crohn’s disease health states
|
Rencz, Fanni
|
|
2019
|
|
supplement-1 |
p. 91-100
|
artikel
|
| 36 |
Patient experiences with outpatient care in Hungary: results of an online population survey
|
Brito Fernandes, Óscar
|
|
2019
|
|
supplement-1 |
p. 79-90
|
artikel
|
| 37 |
Patient-reported outcomes: opportunities and challenges in Central Europe
|
Péntek, Márta
|
|
2019
|
|
supplement-1 |
p. 1-3
|
artikel
|
| 38 |
Poster presentations
|
|
|
2007
|
|
supplement-1 |
p. 105-138
|
artikel
|
| 39 |
Psychometric properties of the Hungarian version of the eHealth Literacy Scale
|
Zrubka, Zsombor
|
|
2019
|
|
supplement-1 |
p. 57-69
|
artikel
|
| 40 |
Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis
|
Gulyas, Katalin
|
|
2014
|
|
supplement-1 |
p. 93-100
|
artikel
|
| 41 |
Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
|
Chevreul, Karine
|
|
2016
|
|
supplement-1 |
p. 7-18
|
artikel
|
| 42 |
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
|
Cavazza, Marianna
|
|
2016
|
|
supplement-1 |
p. 19-29
|
artikel
|
| 43 |
Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
|
Angelis, Aris
|
|
2016
|
|
supplement-1 |
p. 31-42
|
artikel
|
| 44 |
Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe
|
Chevreul, Karine
|
|
2016
|
|
supplement-1 |
p. 43-52
|
artikel
|
| 45 |
Social/economic costs and health-related quality of life in patients with histiocytosis in Europe
|
Iskrov, Georgi
|
|
2016
|
|
supplement-1 |
p. 67-78
|
artikel
|
| 46 |
Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
|
Kuhlmann, A.
|
|
2016
|
|
supplement-1 |
p. 79-87
|
artikel
|
| 47 |
Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe
|
López-Bastida, Julio
|
|
2016
|
|
supplement-1 |
p. 99-108
|
artikel
|
| 48 |
Social/economic costs and health-related quality of life in patients with rare diseases in Europe
|
López-Bastida, Julio
|
|
2016
|
|
supplement-1 |
p. 1-5
|
artikel
|
| 49 |
Social/economic costs and health-related quality of life in patients with scleroderma in Europe
|
López-Bastida, Julio
|
|
2016
|
|
supplement-1 |
p. 109-117
|
artikel
|
| 50 |
Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
|
Péntek, Márta
|
|
2016
|
|
supplement-1 |
p. 89-98
|
artikel
|
| 51 |
Social/economic costs and quality of life in patients with haemophilia in Europe
|
Cavazza, Marianna
|
|
2016
|
|
supplement-1 |
p. 53-65
|
artikel
|
| 52 |
Statistical and regulatory considerations in assessments of interchangeability of biological drug products
|
Tóthfalusi, Lászlo
|
|
2014
|
|
supplement-1 |
p. 5-11
|
artikel
|
| 53 |
Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
|
Péntek, Márta
|
|
2019
|
|
supplement-1 |
p. 17-30
|
artikel
|
| 54 |
Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
|
Péntek, Márta
|
|
2014
|
|
supplement-1 |
p. 83-92
|
artikel
|
| 55 |
Subjective well-being in patients with pemphigus: a path analysis
|
Mitev, Ariel
|
|
2019
|
|
supplement-1 |
p. 101-107
|
artikel
|
| 56 |
The burden of colorectal cancer: prevention, treatment and quality of services
|
Kanavos, Panos
|
|
2009
|
|
supplement-1 |
p. 1-3
|
artikel
|
| 57 |
The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys
|
Baji, Petra
|
|
2019
|
|
supplement-1 |
p. 5-16
|
artikel
|
| 58 |
The challenge of colorectal cancer prevention in Spain
|
Lopez-Bastida, Julio
|
|
2009
|
|
supplement-1 |
p. 75-83
|
artikel
|
| 59 |
The development of new research methods for the valuation of EQ-5D-5L
|
Devlin, Nancy J.
|
|
2013
|
|
supplement-1 |
p. 1-3
|
artikel
|
| 60 |
The disease burden of colorectal cancer in Hungary
|
Boncz, Imre
|
|
2009
|
|
supplement-1 |
p. 35-40
|
artikel
|
| 61 |
The dynamics of colorectal cancer management in 17 countries
|
Kanavos, Panos
|
|
2009
|
|
supplement-1 |
p. 115-129
|
artikel
|
| 62 |
The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework
|
Luo, Nan
|
|
2013
|
|
supplement-1 |
p. 15-24
|
artikel
|
| 63 |
The status of colorectal cancer care in the Netherlands: past, present and future
|
Schurer, Willemien
|
|
2009
|
|
supplement-1 |
p. 51-56
|
artikel
|
| 64 |
Time to tweak the TTO: results from a comparison of alternative specifications of the TTO
|
Versteegh, Matthijs M.
|
|
2013
|
|
supplement-1 |
p. 43-51
|
artikel
|
| 65 |
Time trade-off: one methodology, different methods
|
Attema, Arthur E.
|
|
2013
|
|
supplement-1 |
p. 53-64
|
artikel
|
| 66 |
Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
|
Zrubka, Zsombor
|
|
2019
|
|
supplement-1 |
p. 141-154
|
artikel
|
| 67 |
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
|
Gulácsi, László
|
|
2014
|
|
supplement-1 |
p. 27-34
|
artikel
|
| 68 |
Unmet medical needs in ambulatory care in Hungary: forgone visits and medications from a representative population survey
|
Lucevic, Armin
|
|
2019
|
|
supplement-1 |
p. 71-78
|
artikel
|
| 69 |
Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
|
Rencz, Fanni
|
|
2019
|
|
supplement-1 |
p. 43-55
|
artikel
|
| 70 |
Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
|
Michael, Mandel D.
|
|
2014
|
|
supplement-1 |
p. 121-128
|
artikel
|
Tijdschrift beschrijving